All articles tagged with #centene
Major insurers are discontinuing unprofitable Medicare Advantage plans, forcing approximately five million beneficiaries to switch coverage for 2027. This shift is expected to raise out-of-pocket costs for prescriptions and medical care, particularly in rural areas where options are vanishing.
Centene reported Q2 2026 revenue of $53.6 billion with GAAP earnings per share of $2.19 and adjusted EPS of $2.51, and raised its full-year guidance to greater than $3.11 in GAAP EPS and greater than $4.80 in adjusted EPS. Total premium and service revenues were $44.38 billion on $53.58 billion total revenues, with a health benefits ratio of 89.6% and SG&A ratios of 7.0% (GAAP) and 6.9% (adjusted). The company also cited cash flow from operations of about $3.6 billion, debt repurchases totaling $260 million, and a favorable profitability trajectory driven by cost management and higher PDP/Marketplace performance, along with updated 2026 full-year revenue guidance of roughly $193.5-$197.5 billion and premium/service revenue guidance of $173.0-$177.0 billion. The Q2 results include a membership mix improvement and ongoing execution in Medicaid, Commercial, and Medicare segments, contributing to the improved outlook.
Centene is offering a companywide voluntary buyout program to trim payroll costs as part of broader cost-cutting efforts in its healthcare business.
Centene announced a voluntary separation program offering buyouts to some employees as it confronts higher medical costs, funding cuts and a shrinking member base. The company did not disclose how many workers are impacted or the target layoffs. The move follows a Q1 membership drop of 6% year over year to 26.3 million, with ACA membership down about 2 million in Q1 and an expectation that ACA membership could fall roughly 40% by the end of 2026. Shares dipped about 4% after Bloomberg first reported the plan, and layoffs could follow if the separation targets aren’t met.
A class action lawsuit was filed against Centene Corporation alleging that the company and its executives made false and misleading statements about its revenue outlook and growth prospects, leading to a significant stock decline after the company withdrew its fiscal guidance and revealed lower-than-expected market growth, resulting in substantial financial losses for investors.
Stocks experienced modest gains with the S&P 500 on track for its fifth consecutive record close. Key movers included Intel, which reported strong revenue but posted an unexpected loss; Centene, which rebounded after a surprise loss; Tesla, which rose after a decline; and Deckers, which saw significant earnings growth. Other notable movements involved Newmont, Edwards Lifesciences, and Boston Beer, reflecting varied company performances amid ongoing market dynamics.
Centene's stock rebounded despite reporting a surprise quarterly loss due to higher medical costs and an increased health benefits ratio, with investors possibly seeing it as a buying opportunity amid broader sector concerns.
Shares of Centene (CNC) dropped 40% after the company unexpectedly withdrew its 2025 guidance due to slower ACA plan growth and higher Medicaid costs, leading to analyst downgrades and concerns about its near-term outlook. Despite a moderate buy consensus, the stock faces significant headwinds from risk adjustment shortfalls and regulatory uncertainties.
Stocks rose following a U.S.-Vietnam trade deal announcement, with Tesla and Apple gaining on strong deliveries and analyst upgrades, while Centene dropped 40% after withdrawing earnings guidance. Major banks announced increased dividends and buybacks, Verint Systems surged on acquisition rumors, and Greenbrier jumped after strong earnings. Other notable movements included declines in Adobe and mixed performances in quantum computing stocks.
Shares of Centene plummeted over 32% after the company withdrew its 2025 guidance due to poor risk adjustment results and ongoing cost pressures, leading Wall Street to downgrade ratings and cut price targets, highlighting challenges in its ACA exchange and Medicaid segments.
Centene's stock plummeted nearly 40% after the company withdrew its 2025 financial guidance due to higher-than-expected healthcare costs and lower-than-anticipated demand for coverage, reflecting broader challenges in the health insurance sector and raising concerns about future profitability.
Centene's stock dropped 20% after the company withdrew its 2025 earnings guidance due to unexpected challenges in its Marketplace business and rising Medicaid costs, including lower-than-expected market growth and higher morbidity rates, leading to revised revenue and earnings projections. Despite these issues, its Medicare businesses are performing well, and the company plans to update its financial outlook in late July 2025.
The murder of UnitedHealthcare CEO Brian Thompson has prompted health insurers like Centene to switch to virtual meetings and remove executive photos from websites due to safety concerns. Thompson was shot in New York, and police suspect he was targeted. The incident has led to increased security measures and discussions about executive protection in the industry.
Health insurance company Centene plans to lay off approximately 2,000 employees, representing just over 3% of its workforce, starting on October 2. The decision comes as Centene aims to improve its cost structure and ensure it has the necessary talent and expertise to support its members and evolving business needs. Impacted employees will receive severance packages and outplacement services.